CDIOW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CTCXW, SAVAW, and CELUW
Should you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
Cardio Diagnostics (NASDAQ:CDIOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and community ranking.
In the previous week, 180 Life Sciences had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Cardio Diagnostics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
Cardio Diagnostics and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.
Get Cardio Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CDIOW vs. The Competition
Cardio Diagnostics Competitors List
Related Companies and Tools
